Effects of oral treatment with chondroitin sulfate and glucosamine in an experimental model of metacarpophalangeal osteoarthritis in horses.
Authors: Yamada Ana Lucia Miluzzi, do Prado Vendruscolo Cynthia, Marsiglia Marília Ferrari, Sotelo Eric Danilo Pauls, Agreste Fernanda Rodrigues, Seidel Sarah Raphaela Torquato, Fülber Joice, Baccarin Raquel Yvonne Arantes, da Silva Luis Claudio Lopes Correia
Journal: BMC veterinary research
Summary
# Editorial Summary Researchers at the University of São Paulo investigated whether oral chondroitin sulfate and glucosamine could modify the progression of experimentally induced osteoarthritis (OA) in the metacarpophalangeal joint, comparing eight treated horses with eight untreated controls over 120 days. The study combined clinical assessment, ultrasonographic and radiographic imaging, synovial fluid biomarker analysis, and final arthroscopic evaluation with histological examination to track disease development and treatment effects. Although the authors hypothesised that these supplements would reduce cartilage degradation through pain modulation (chondroitin sulfate) and glycosaminoglycan synthesis stimulation (glucosamine), the results appear to challenge the widespread clinical use of these oral formulations in equine practice. This controlled experimental model provides valuable evidence regarding the actual efficacy of combined CS and GlcN supplementation—evidence that practitioners should weigh carefully against the theoretical mechanisms and routine recommendations within the industry. Given the significant investment many equine professionals and owners place in oral joint supplements, understanding whether marketed formulations genuinely slow OA progression in horses warrants scrutiny of the full findings and consideration of alternative or adjunctive management strategies.
Read the full abstract on PubMed
Practical Takeaways
- •Oral chondroitin sulfate and glucosamine supplements are commonly used for osteoarthritis management, but this controlled study helps clarify whether they actually modify disease progression in horses
- •Monitor treated horses using objective measures (ultrasound, radiographs, synovial fluid markers) rather than clinical signs alone, as these may not reflect underlying joint changes
- •Results from this experimental lesion model may inform supplement recommendations for horses with naturally occurring osteoarthritis, though further studies may be needed
Key Findings
- •Oral chondroitin sulfate and glucosamine treatment was administered to 8 horses with experimentally induced metacarpophalangeal joint lesions over 120 days
- •Study evaluated disease progression through physical, ultrasonographic, radiographic examinations and synovial fluid biomarkers at multiple time points (days 0, 30, 60, 90, 120)
- •Final arthroscopic evaluation with macroscopic and microscopic analysis was performed to assess treatment effectiveness on joint cartilage lesions